Skip to main content

and
  1. Article

    Open Access

    The relationship between tumour dosimetry, response, and overall survival in patients with unresectable Neuroendocrine Neoplasms (NEN) treated with 177Lu DOTATATE (LuTate)

    Peptide Receptor Radionuclide Therapy (PRRT) delivers targeted radiation to Somatostatin Receptor (SSR) expressing Neuroendocrine Neoplasms (NEN). We sought to assess the predictive and prognostic implications...

    R. Alipour, P. Jackson, M. Bressel, A. Hogg in European Journal of Nuclear Medicine and M… (2023)

  2. Article

    Open Access

    Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors

    Response assessment in the context of immunomodulatory treatments represents a major challenge for the medical imaging community and requires a multidisciplinary approach with involvement of oncologists, radio...

    E. Lopci, N. Aide, A. Dimitrakopoulou-Strauss, L. Dercle, A. Iravani in Cancer Imaging (2022)

  3. Article

    Open Access

    Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0

    The goal of this guideline/procedure standard is to assist nuclear medicine physicians, other nuclear medicine professionals, oncologists or other medical specialists for recommended use of [18F]FDG PET/CT in onc...

    E. Lopci, R. J. Hicks in European Journal of Nuclear Medicine and M… (2022)

  4. Article

    Open Access

    Advancing Biomarker Development Through Convergent Engagement: Summary Report of the 2nd International Danube Symposium on Biomarker Development, Molecular Imaging and Applied Diagnostics; March 14–16, 2018; Vienna, Austria

    Here, we report on the outcome of the 2nd International Danube Symposium on advanced biomarker development that was held in Vienna, Austria, in early 2018. During the meeting, cross-speciality participants ass...

    M. S. Lim, Thomas Beyer, A. Babayan, M. Bergmann in Molecular Imaging and Biology (2020)

  5. No Access

    Article

    FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging

    Invasive fungal infections (IFIs) are common in immunocompromised patients. While early diagnosis can reduce otherwise high morbidity and mortality, conventional CT has suboptimal sensitivity and specificity. ...

    A. P. Douglas, K. A. Thursky, L. J. Worth in European Journal of Nuclear Medicine and M… (2019)

  6. Article

    Life is not black and white, nor just Shades of Gray

    T. Beyer, R. J. Hicks, L. S. Freudenberg in European Journal of Nuclear Medicine and M… (2018)

  7. Article

    Open Access

    Combined PET/MRI: from Status Quo to Status Go. Summary Report of the Fifth International Workshop on PET/MR Imaging; February 15–19, 2016; Tübingen, Germany

    This article provides a collaborative perspective of the discussions and conclusions from the fifth international workshop of combined positron emission tomorgraphy (PET)/magnetic resonance imaging (MRI) that ...

    D. L. Bailey, B. J. Pichler, B. Gückel, H. Barthel in Molecular Imaging and Biology (2016)

  8. Article

    Open Access

    A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma

    Preoperative radiotherapy (RT) is commonly used to treat localised soft-tissue sarcomas (STS). Hypoxia is an important determinant of radioresistance. Whether antiangiogenic therapy can ‘normalise’ tumour vasc...

    J Lewin, K K Khamly, R J Young, C Mitchell, R J Hicks in British Journal of Cancer (2014)

  9. Article

    Open Access

    Limited role for surveillance PET–CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy

    The usefulness of positron emission tomography with computed tomography (PET–CT) in the surveillance of patients with diffuse large B-cell lymphoma (DLBCL) in complete metabolic remission after primary therapy...

    C Y Cheah, M S Hofman, M Dickinson, A Wirth, D Westerman in British Journal of Cancer (2013)

  10. Article

    Open Access

    FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy

    The aim was to investigate the correlation between 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) metabolic response to chemoradiotherapy and clinical outcomes in squamous cell carcinoma (SCC) of t...

    F L Day, E Link, S Ngan, T Leong, K Moodie, C Lynch, M Michael in British Journal of Cancer (2011)

  11. Article

    Open Access

    The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer

    Accurate inguinal and pelvic nodal staging in anal cancer is important for the prognosis and planning of radiation fields. There is evidence for the role of 18-fluorodeoxyglucose positron emission tomography (...

    E de Winton, A G Heriot, M Ng, R J Hicks, A Hogg, A Milner in British Journal of Cancer (2009)

  12. No Access

    Article

    Claimed association of absolute lymphocyte count with therapeutic efficacy of radio-immunotherapy in patients with indolent lymphoma cannot be verified in an independent data set

    M J Bishton, R J Hicks, H M Prince, D S Ritchie, M Wolf, J F Seymour in Leukemia (2008)

  13. No Access

    Article

    The clinical application of PET/CT: a contemporary review

    The combination of positron emission tomography (PET) scanners and x-ray computed tomography (CT) scanners into a single PET/CT scanner has resulted in significant improvements in the diagnosis and staging of ...

    Z. Brady, M. L. Taylor, M. Haynes in Australasian Physics & Engineering Science… (2008)

  14. No Access

    Article

    In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma

    Radio-labelling of blood cells is an established technique for evaluating in vivo migration of normal cells to sites of pathology such as infection and haemorrhage. A limitation of cellular immunotherapies to ...

    D. Ritchie, L. Mileshkin, D. Wall, J. Bartholeyns in Cancer Immunology, Immunotherapy (2007)

  15. Article

    Open Access

    Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial

    The aim of this study was to define the recommended dose of oxaliplatin when combined with infusional 5-fluorouracil (5-FU) and concurrent pelvic radiotherapy. Eligible patients had inoperable rectal cancer, o...

    S Loi, S Y K Ngan, R J Hicks, B Mukesh, P Mitchell, M Michael in British Journal of Cancer (2005)

  16. No Access

    Article

    Gene expression profiling and treatment response in esophageal cancers

    C. P. Duong, A. Kowalczyk, A. Thompson, R. Chen, J. Spillane in Annals of Surgical Oncology (2004)

  17. No Access

    Article

    Clinical impact of FDG-PET on the management of esophageal cancer

    C. P. Duong, H. Demitriou, A. Thompson, L. Weih in Annals of Surgical Oncology (2004)

  18. No Access

    Article

    Display of positron emission tomography with Cadplan

    Recent clinical experience at Peter MacCallum Cancer Institute1 (PMCI) with the use of unregistered Positron Emission Tomography (PET) images for radiotherapy target marking in the lung suggests that co-registere...

    T. Ackerly, J. Andrews, D. Ball, D. Binns in Australasian Physics & Engineering Science… (2002)